Inhibiting the expression of IL-1β has been shown to reduce tumor growth and prevent the shedding of tumor cells from the primary site into circulation (Kaplanov et al., 2019; Tulotta et al., 2019; Zhang and Veeramachaneni, 2022). Here, IL1B is linked to neoplasm.